Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.

[1]  F. LaFerla,et al.  Enhanced caffeine‐induced Ca2+ release in the 3xTg‐AD mouse model of Alzheimer's disease , 2005, Journal of neurochemistry.

[2]  Stephen T. Brown,et al.  Hypoxic Augmentation of Ca2+ Channel Currents Requires a Functional Electron Transport Chain* , 2005, Journal of Biological Chemistry.

[3]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[4]  W. K. Cullen,et al.  Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.

[5]  M. Lussier,et al.  The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells. , 2005, Cellular signalling.

[6]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[7]  S. Ball,et al.  Alzheimer’s amyloid peptides mediate hypoxic up‐regulation of L‐type Ca2+ channels , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  E. Rojas,et al.  Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity , 1995, Cellular and Molecular Neurobiology.

[9]  C. Glabe.  Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Abeta. , 2005, Sub-cellular biochemistry.

[10]  W. K. Cullen,et al.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.

[11]  F. LaFerla,et al.  Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity. , 2004, Biochemical and biophysical research communications.

[12]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[13]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[14]  T. Pozzan,et al.  The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores , 2004, Neurobiology of Disease.

[15]  Grace E Stutzmann,et al.  Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.

[16]  E. Rojas,et al.  β-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease , 1994, Molecular and Cellular Biochemistry.

[17]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[18]  J. J. Dougherty,et al.  β-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex , 2003, The Journal of Neuroscience.

[19]  M. Berridge,et al.  Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.

[20]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[21]  H. Kretzschmar,et al.  Capacitive Calcium Entry Is Directly Attenuated by Mutant Presenilin-1, Independent of the Expression of the Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[22]  M. Freeman.  Faculty Opinions recommendation of PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. , 2002 .

[23]  G. Collingridge,et al.  Calcium stores and synaptic plasticity. , 2002, Cell calcium.

[24]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[25]  Harald Steiner,et al.  PEN-2 Is an Integral Component of the γ-Secretase Complex Required for Coordinated Expression of Presenilin and Nicastrin* , 2002, The Journal of Biological Chemistry.

[26]  R. Cowburn,et al.  The Presenilin 1 ΔE9 Mutation Gives Enhanced Basal Phospholipase C Activity and a Resultant Increase in Intracellular Calcium Concentrations* , 2002, The Journal of Biological Chemistry.

[27]  R. Cowburn,et al.  Ca2+ Stores and capacitative Ca2+ entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer’s disease presenilin-1 mutation , 2002, Brain Research.

[28]  M. Duchen,et al.  β-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons , 2002, Neurobiology of Disease.

[29]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[30]  M. Mattson,et al.  The Lipid Peroxidation Product 4-Hydroxynonenal Facilitates Opening of Voltage-dependent Ca2+ Channels in Neurons by Increasing Protein Tyrosine Phosphorylation* , 2002, The Journal of Biological Chemistry.

[31]  Wei Xu,et al.  aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation , 2002 .

[32]  C. Peers,et al.  Divergent pathways account for two distinct effects of amyloid β peptides on exocytosis and Ca2+ currents: involvement of ROS and NF‐κB , 2002, Journal of neurochemistry.

[33]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[34]  B. de Strooper,et al.  A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Blake.  Amyloid Precursor Protein , 2002 .

[36]  M. Duchen,et al.  Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. , 2002, Neurobiology of disease.

[37]  Y. Suh,et al.  Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. , 2002, Pharmacological reviews.

[38]  B. de Strooper,et al.  A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Selkoe,et al.  Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.

[40]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[41]  M. C. Ellis,et al.  aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. , 2002, Developmental cell.

[42]  P. Vaughan,et al.  Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones , 2001, Journal of neurochemistry.

[43]  C. Peers,et al.  Effects of chronic hypoxia on Ca2+ stores and capacitative Ca2+ entry in human neuroblastoma (SH‐SY5Y) cells , 2001, Journal of neurochemistry.

[44]  E. Parker,et al.  PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Winblad,et al.  Caspase cleavage of exon 9 deleted presenilin‐1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH‐SY5Y neuroblastoma cells , 2001, Journal of neuroscience research.

[46]  A. Konnerth,et al.  Stores Not Just for Storage Intracellular Calcium Release and Synaptic Plasticity , 2001, Neuron.

[47]  T. Aosaki,et al.  Deficiency of presenilin‐1 increases calcium‐dependent vulnerability of neurons to oxidative stress in vitro , 2001, Journal of neurochemistry.

[48]  C. Peers,et al.  Amyloid β peptides mediate hypoxic augmentation of Ca2+ channels , 2001, Journal of neurochemistry.

[49]  E. Godaux,et al.  Mutant Presenilins Disturb Neuronal Calcium Homeostasis in the Brain of Transgenic Mice, Decreasing the Threshold for Excitotoxicity and Facilitating Long-term Potentiation* , 2001, The Journal of Biological Chemistry.

[50]  M. Frosch,et al.  Presenilin-Mediated Modulation of Capacitative Calcium Entry , 2000, Neuron.

[51]  A. Thomson.  Facilitation, augmentation and potentiation at central synapses , 2000, Trends in Neurosciences.

[52]  M. Mattson,et al.  Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.

[53]  Hai Lin,et al.  Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  M. Mattson,et al.  Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.

[55]  Masahiro Kawahara,et al.  Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line* , 2000, The Journal of Biological Chemistry.

[56]  R. Empson,et al.  Functional Phenotype in Transgenic Mice Expressing Mutant Human Presenilin-1 , 2000, Neurobiology of Disease.

[57]  Z. Henderson,et al.  Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. , 2000, The Journal of biological chemistry.

[58]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[59]  M. Tabaton,et al.  Generation of an Apoptotic Intracellular Peptide by γ-Secretase Cleavage of Alzheimer's Amyloid ß Protein Precursor , 2000 .

[60]  M. Tabaton,et al.  Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. , 2000, Journal of Alzheimer's disease : JAD.

[61]  M. Kawahara,et al.  Alzheimer’s b -Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line* , 2000 .

[62]  M. Mattson,et al.  Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.

[63]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[64]  F. LaFerla,et al.  Presenilin-2 Mutations Modulate Amplitude and Kinetics of Inositol 1,4,5-Trisphosphate-mediated Calcium Signals* , 1999, The Journal of Biological Chemistry.

[65]  C. Peers,et al.  Hypoxic Enhancement of Quantal Catecholamine Secretion , 1999, The Journal of Biological Chemistry.

[66]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[67]  K. Malik,et al.  Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. , 1999, The Journal of biological chemistry.

[68]  M. Duchen,et al.  Mitochondria Exert a Negative Feedback on the Propagation of Intracellular Ca2+ Waves in Rat Cortical Astrocytes , 1999, The Journal of cell biology.

[69]  Haruhisa Inoue,et al.  Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation , 1999, Nature Medicine.

[70]  E. Kojro,et al.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Cotman,et al.  Alzheimer's Presenilin-1 Mutation Potentiates Inositol 1,4,5-Trisphosphate-Mediated Calcium Signaling in Xenopus , 1999 .

[72]  M. Mattson,et al.  Altered Calcium Homeostasis and Mitochondrial Dysfunction in Cortical Synaptic Compartments of Presenilin‐1 Mutant Mice , 1999, Journal of neurochemistry.

[73]  D. Linden,et al.  Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1 , 1999, Neurobiology of Disease.

[74]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[75]  C. Southan,et al.  Identification of a novel aspartic protease (Asp 2) as beta-secretase. , 1999, Molecular and cellular neurosciences.

[76]  Miles W. Miller,et al.  Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.

[77]  Joseph D. Buxbaum,et al.  Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.

[78]  D. Alkon,et al.  Calcium Responses in Fibroblasts from Asymptomatic Members of Alzheimer's Disease Families , 1998, Neurobiology of Disease.

[79]  M. Mattson,et al.  Increased Sensitivity to Mitochondrial Toxin-Induced Apoptosis in Neural Cells Expressing Mutant Presenilin-1 Is Linked to Perturbed Calcium Homeostasis and Enhanced Oxyradical Production , 1998, The Journal of Neuroscience.

[80]  G. Schellenberg,et al.  Presenilin‐1 mutation alters NGF‐induced neurite outgrowth, calcium homeostasis, and transcription factor (AP‐1) activation in PC12 cells , 1998, Journal of neuroscience research.

[81]  R. Lal,et al.  Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel* , 1998, The Journal of Biological Chemistry.

[82]  M. Mattson,et al.  Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[84]  D L Price,et al.  Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.

[85]  J. Buxbaum,et al.  Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. , 1998, The Journal of biological chemistry.

[86]  M. Mattson,et al.  Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.

[87]  M. Kawahara,et al.  Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. , 1997, Biophysical journal.

[88]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[89]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[90]  K. Kawasaki,et al.  Amyloid β Protein Potentiates Ca2+ Influx Through L‐Type Voltage‐Sensitive Ca2+ Channels: A Possible Involvement of Free Radicals , 1997, Journal of neurochemistry.

[91]  M. Mattson,et al.  Alzheimer's PS‐1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β‐peptide , 1996, Neuroreport.

[92]  Daniel L. Alkon,et al.  Calcium responses in human fibroblasts: A diagnostic molecular profile for Alzheimer's disease , 1996, Neurobiology of Aging.

[93]  L. Toral-Barza,et al.  Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. , 1996, Biochimica et biophysica acta.

[94]  E. Rojas,et al.  Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Hardy,et al.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. , 1996, Nature medicine.

[96]  R. Anwyl,et al.  beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. , 1995, Neuroreport.

[97]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[99]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[100]  J. C. Chisholm,et al.  The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. , 1995, Journal of neurobiology.

[101]  M. Takeda,et al.  Cell cycle dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease , 1994, Neurobiology of Aging.

[102]  R. Davidson,et al.  Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells , 1994, Brain Research.

[103]  C. Cotman,et al.  Rapid Communication: Ca2+ Channel Blockers Attenuate β‐Amyloid Peptide Toxicity to Cortical Neurons in Culture , 1994 .

[104]  C. Cotman,et al.  Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. , 1994, Journal of neurochemistry.

[105]  E. Rojas,et al.  beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. , 1994, Molecular and cellular biochemistry.

[106]  E. Rojas,et al.  Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[107]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[108]  D. Selkoe,et al.  beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. , 1993, The Journal of biological chemistry.

[109]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[110]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[111]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[112]  M. Shelanski,et al.  Changes in Calcium Homeostasis during Aging and Alzheimer's Disease a , 1989, Annals of the New York Academy of Sciences.

[113]  K. Ogomori,et al.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. , 1989, The American journal of pathology.

[114]  J. Goldman,et al.  Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium , 1988, Neurobiology of Aging.

[115]  J. Blass,et al.  Diminished mitogen-induced calcium uptake by lymphocytes from alzheimer patients , 1987, Biological Psychiatry.

[116]  L. Jarvik,et al.  About a peculiar disease of the cerebral cortex. By Alois Alzheimer, 1907 (Translated by L. Jarvik and H. Greenson) , 1986, Alzheimer disease and associated disorders.

[117]  J. Goldman,et al.  Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J. Goldman,et al.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Blass,et al.  Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. , 1985, The New England journal of medicine.

[120]  T. Bliss,et al.  Long‐lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path , 1973, The Journal of physiology.